Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Ovarian Neoplasms

Free Subscription Articles published in Int J Gynecol Pathol Retrieve available abstracts of 143 articles: HTML format

Single Articles

September 2024
1. VAZIRI FARD E, Imboden S, Rau T, Epstein E, et al
   p53 Abnormal (Copy Number High) Endometrioid Endometrial Carcinoma Has a Prognosis Indistinguishable From Serous Carcinoma.
   Int J Gynecol Pathol. 2024;43:515-526.
   PubMed     Abstract available
   
   
   
2. MOH M, Puzyrenko A, Summey R, Rader JS, et al
   Clinicopathologic Characteristics of a Single-institution Cohort of Ovarian Adult Granulosa Cell Tumors, With Biomarker and Therapeutic Implications Utilizing the Detection of Androgen, Estrogen, and Progesterone Hormone Receptor Expression by Immunoh
   Int J Gynecol Pathol. 2024;43:527-534.
   PubMed     Abstract available
   
   
   
3. HUVILA J, Jamieson A, Pors J, Hoang L, et al
   Endometrial Carcinosarcomas are Almost Exclusively of p53abn Molecular Subtype After Exclusion of Mimics.
   Int J Gynecol Pathol. 2024;43:506-514.
   PubMed     Abstract available
   
   
   
4. LIU N, Lin W, Wang Y, Yao Z, et al
   Predicting Progestin Therapy Response With PTEN, PAX2, and beta-Catenin in Patients With Endometrioid Precancer.
   Int J Gynecol Pathol. 2024;43:494-505.
   PubMed     Abstract available
   
   
   July 2024
5. MIYAMA Y, Ogasawara A, Hasegawa K, Yasuda M, et al
   Premature Classification of Early-stage Endometrioid Ovarian Carcinoma With Mesonephric-like Differentiation as Mesonephric-like Adenocarcinoma.
   Int J Gynecol Pathol. 2024;43:362-372.
   PubMed     Abstract available
   
   
   
6. GILMORE B, Logan L, McKinnon W, Everett E, et al
   Endometrial Cancer in a Family With RAD51D Gene Mutation.
   Int J Gynecol Pathol. 2024;43:349-353.
   PubMed     Abstract available
   
   
   
7. VIKI M, Morrow R
   Metastatic Hepatocellular Carcinoma Represents an Important but Rare Pitfall in the Diagnostic Evaluation of ER Negative Ovarian Malignancy: A Case Report.
   Int J Gynecol Pathol. 2024;43:378-381.
   PubMed     Abstract available
   
   
   
8. ZHAO Z, Nadarajah R, Busmanis I
   Synchronous Bilateral Ovarian Mesonephric-like Adenocarcinomas with Separate Origins from High-Grade Mullerian Adenosarcoma and Endometriosis: Report of a Rare Case.
   Int J Gynecol Pathol. 2024;43:382-388.
   PubMed     Abstract available
   
   
   
9. GUERRIERO A, Moro M, Angerilli V, Munari G, et al
   Synchronous Endometrial and Ovarian Carcinomas: Pathologic and Molecular Analysis Highlights the Monoclonal Origin of the Lesions.
   Int J Gynecol Pathol. 2024;43:309-315.
   PubMed     Abstract available
   
   
   
10. WANG SC, Wu CH, Fu HC, Ou YC, et al
    Estrogen/Progesterone Receptor Expression and Cancer Antigen 125 Level as Preoperative Predictors to Estimate Lymph Node Metastasis in Endometrioid Endometrial Cancer.
    Int J Gynecol Pathol. 2024;43:316-325.
    PubMed     Abstract available
    
    
    
11. AL-HUSSAINI M, McCluggage WG
    SATB2 Cytoplasmic Expression is Characteristic of a Subset of Ovarian Stromal Cells and Sex Cord Stromal Tumors.
    Int J Gynecol Pathol. 2024;43:373-377.
    PubMed     Abstract available
    
    
    June 2024
12. WALIA A, Ladwig NR, Mak JS, Rabban JT, et al
    Prevalence of Occult Ovarian Cancer and Metastatic Breast Cancer in Ovarian Ablation Specimens of Patients With Hormone Receptor-Positive Breast Cancer: Implications for Tissue Sampling Strategies, Early Ovarian Cancer Detection and Resource Utilizati
    Int J Gynecol Pathol. 2024 Jun 26. doi: 10.1097/PGP.0000000000001055.
    PubMed     Abstract available
    
    
    May 2024
13. ALROHAIBANI A, Yu Y, Gao L, McLean KM, et al
    PReferentially Expressed Antigen in MElanoma Expression in Uterine and Ovarian Carcinosarcomas.
    Int J Gynecol Pathol. 2024;43:284-289.
    PubMed     Abstract available
    
    
    
14. YAMAMOTO A, Nagai T, Sukeda A, Kajiwara M, et al
    Ovarian Mesonephric-like Adenocarcinoma Recurring With a Rhabdomyosarcoma Component: A Case Report.
    Int J Gynecol Pathol. 2024;43:296-301.
    PubMed     Abstract available
    
    
    
15. LI Y, Chen J, Niu S
    Endometrioid Adenocarcinoma With "Burrowing" Invasion of the Cervix Represents a Separate Primary From the Concurrent Uterine Corpus Endometrial Endometrioid Adenocarcinoma: Histology, Immunohistochemistry, and Next-generation Sequencing Study of a Si
    Int J Gynecol Pathol. 2024;43:271-274.
    PubMed     Abstract available
    
    
    
16. XU J, Weisman PS
    Divergent Malignant Melanocytic Differentiation in Ovarian Endometrioid Adenocarcinoma With Aberrant beta-Catenin Expression: A Case Expanding the Histologic Spectrum of beta-Catenin Activated Gynecologic Neoplasia.
    Int J Gynecol Pathol. 2024;43:302-307.
    PubMed     Abstract available
    
    
    
17. JU B, Wu J, Sun L, Yang C, et al
    Molecular Classification of Endometrial Endometrioid Carcinoma With Microcystic Elongated and Fragmented Pattern.
    Int J Gynecol Pathol. 2024;43:233-241.
    PubMed     Abstract available
    
    
    
18. LEE Y, Choi S, Kim HS
    Comprehensive Immunohistochemical Analysis of Mesonephric Marker Expression in Low-grade Endometrial Endometrioid Carcinoma.
    Int J Gynecol Pathol. 2024;43:221-232.
    PubMed     Abstract available
    
    
    March 2024
19. HAN R, Madariaga A, Gonzalez-Ochoa E, Smith AC, et al
    HER2-low and Overexpression in Mucinous Ovarian Cancer: Analysis of ASCO/CAP and ToGA Immunohistochemical Scoring.
    Int J Gynecol Pathol. 2024 Mar 4. doi: 10.1097/PGP.0000000000000972.
    PubMed     Abstract available
    
    
    
20. XU J, McGregor SM, Park KJ, Weisman PS, et al
    Ovarian Endometrioid Adenocarcinomas With Infiltrative "Adenofibroma-like" Morphology and Aberrant ss-catenin Expression: Tumors That Coexpress CDX2 and LEF1 With Frequent Neuroendocrine Marker Expression, Diminished/Lost PAX8 and Possible Association
    Int J Gynecol Pathol. 2024;43:145-148.
    PubMed    
    
    
    
21. BHARDWAJ S, Banet N, Gaston EC
    Moderately-differentiated Ovarian Sertoli-Leydig Cell Tumor With a Concurrent Serous Borderline Tumor in a 16-year-old Girl.
    Int J Gynecol Pathol. 2024;43:140-144.
    PubMed     Abstract available
    
    
    
22. SMITHGALL MC, Yemelyanova A, Mathew S, Gogineni S, et al
    HER2/ ERBB2 Immunohistochemical Expression and Copy Number Status in Ovarian Mucinous Tumors.
    Int J Gynecol Pathol. 2024;43:134-139.
    PubMed     Abstract available
    
    
    
23. KENDALL BARTU M, Nemejcova K, Michalkova R, Bui QH, et al
    Neuroendocrine Marker Expression in Primary Non-neuroendocrine Epithelial Tumors of the Ovary: A Study of 551 Cases.
    Int J Gynecol Pathol. 2024;43:123-133.
    PubMed     Abstract available
    
    
    
24. KANG EY, Terzic T, Ghatage P, Woo L, et al
    TP53 as a Diagnostic Aid in the Distinction of Ovarian Mucinous Borderline Tumors From Mucinous Carcinoma.
    Int J Gynecol Pathol. 2024;43:111-122.
    PubMed     Abstract available
    
    
    January 2024
25. FISCHER EG
    Two Rare Cases of Paratubal Leydig Cell Nodules: Clinical Relevance and Debated Terminology of a Noteworthy Incidentaloma.
    Int J Gynecol Pathol. 2024;43:97-101.
    PubMed     Abstract available
    
    
    
26. ISE K, Tanei ZI, Oda Y, Tanikawa S, et al
    A Case of Uterine Tumor Resembling Ovarian Sex Cord Tumor With Prominent Myxoid Features.
    Int J Gynecol Pathol. 2024;43:41-46.
    PubMed     Abstract available
    
    
    
27. WESSMAN S, Fuentes BB, Severin-Karlsson J, Westbom-Fremer S, et al
    FOXL2 Mutation Status in Sex Cord-stromal Tumors Cannot be Predicted by Morphology.
    Int J Gynecol Pathol. 2024;43:78-89.
    PubMed     Abstract available
    
    
    
28. KAWAGUCHI R, Maehana T, Sugimoto S, Kawahara N, et al
    Immunohistochemical Analysis of the Tissue Factor Pathway Inhibitor-2 in Endometrial Clear Cell Carcinoma: A Single-center Retrospective Study.
    Int J Gynecol Pathol. 2024;43:25-32.
    PubMed     Abstract available
    
    
    
29. XU J, Park KJ, Weisman PS
    An Expanded Series of Pilomatrix-like High-grade Endometrioid Carcinoma (PiMHEC), Including Both MMR Deficient and MMR Proficient Cases.
    Int J Gynecol Pathol. 2024;43:67-69.
    PubMed    
    
    
    
30. ELMUTI L, Amundson J, Oberman E, Kamat A, et al
    Diffuse Pediatric-type High-grade Glioma Arising in an Ovarian Mature Cystic Teratoma.
    Int J Gynecol Pathol. 2024;43:90-96.
    PubMed     Abstract available
    
    
    
31. WEPY C, Nucci MR, Parra-Herran C
    Atypical Endometriosis: Comprehensive Characterization of Clinicopathologic, Immunohistochemical, and Molecular Features.
    Int J Gynecol Pathol. 2024;43:70-77.
    PubMed     Abstract available
    
    
    November 2023
32. YOSHINO Y, Yanai S, Sawada M, Sakate S, et al
    Extraovarian Dysgerminoma Involving the Uterine Cervix: A Rare Case Report With Literature Review.
    Int J Gynecol Pathol. 2023;42:544-549.
    PubMed     Abstract available
    
    
    
33. MATSUMOTO N, Manrai P, Rottmann D, Wu X, et al
    Correlative Assessment of p53 Immunostaining Patterns and TP53 Mutation Status by Next-Generation Sequencing in High-Grade Endometrial Carcinomas.
    Int J Gynecol Pathol. 2023;42:567-575.
    PubMed     Abstract available
    
    
    
34. ALNA'IRAT M, McCluggage WG, Al-Hussaini M
    Ovarian Immature Teratoma With Nodal Gliomatosis: A Case Report and Literature Review.
    Int J Gynecol Pathol. 2023;42:627-631.
    PubMed     Abstract available
    
    
    
35. STOLNICU S, Bartalis RJ, Ye Q, Da Cruz Paula A, et al
    Ovarian RASoma With Mesonephric-like Adenocarcinoma and Mixed Mullerian Components: A Case Report With Molecular Analysis Demonstrating Multidirectional Mullerian Differentiation.
    Int J Gynecol Pathol. 2023;42:620-626.
    PubMed     Abstract available
    
    
    
36. LIN LH, Zamuco RD, Shukla PS
    Ovarian Clear Cell Carcinoma and Markers of Epithelial-Mesenchymal Transition (EMT): Immunohistochemical Characterization of Tumor Budding.
    Int J Gynecol Pathol. 2023;42:602-612.
    PubMed     Abstract available
    
    
    October 2023
37. BICER E, Bese T, Tuzun DD, Ilvan S, et al
    The Relationship Between Melatonin 1-2 Receptor Expression in Patients With Epithelial Ovarian Cancer and Survival.
    Int J Gynecol Pathol. 2023 Oct 4. doi: 10.1097/PGP.0000000000000968.
    PubMed     Abstract available
    
    
    September 2023
38. KEANE E, Floyd R, McDonnell C, Beirne JP, et al
    Endometrioid Adenocarcinoma Resembling Cutaneous Pilomatrix Carcinoma: A Case Report of an Aggressive Neoplasm in a Young Woman With Diffusely Aberrant Beta-catenin Expression and Associated Morular Metaplasia and Atypical Polypoid Adenomyoma-type Cha
    Int J Gynecol Pathol. 2023;42:466-471.
    PubMed     Abstract available
    
    
    
39. DYHDALO KS, Ababneh E, Lanigan C, Bowers K, et al
    Evaluation of Lineage/Site-specific Nuclear Immunohistochemical Markers SATB2, Cyclin D1, SALL4, and BCOR in High-grade Endometrial Carcinomas.
    Int J Gynecol Pathol. 2023;42:443-450.
    PubMed     Abstract available
    
    
    
40. KEYHANIAN K, Yang EJ, Howitt BE
    Nuclear beta-Catenin Expression in the Context of Abnormal p53 Expression Indicates a Nonserous Histotype in Endometrial Carcinoma.
    Int J Gynecol Pathol. 2023;42:435-442.
    PubMed     Abstract available
    
    
    
41. TALIA KL, Ratnayake G, McCluggage WG
    Microscopic Sertoliform Sex Cord Proliferation Involving Pelvic Peritoneum: Report of a Case Associated With Endosalpingiosis.
    Int J Gynecol Pathol. 2023;42:496-499.
    PubMed     Abstract available
    
    
    
42. DONTHI D, Chen H, Peng Y, Niu S, et al
    Ovarian Microcystic Stromal Tumor With Intraovarian Recurrence and Peritoneal and Omental Spread: A Case Report With Morphological, Immunohistochemical, and Molecular Analysis.
    Int J Gynecol Pathol. 2023;42:491-495.
    PubMed     Abstract available
    
    
    
43. CHIESA-VOTTERO AG
    Ovarian Mucinous Borderline Tumor With Intraepithelial Carcinoma.
    Int J Gynecol Pathol. 2023;42:514.
    PubMed    
    
    
    
44. GUERRIERI C, Hudacko R, Anderson P
    Composite FOXL2 Mutation-positive Adult Granulosa Cell Tumor and Serous Borderline Tumor of the Ovary.
    Int J Gynecol Pathol. 2023;42:500-507.
    PubMed     Abstract available
    
    
    
45. CHUI MH, Murali R, Soslow RA, Matrai C, et al
    Interobserver Reproducibility in Assessing Eosinophilic Cells in Ovarian Serous Borderline Tumors to Predict BRAF Mutational Status.
    Int J Gynecol Pathol. 2023;42:472-481.
    PubMed     Abstract available
    
    
    
46. ANDRADE LALA, Alame M, Truffaux N, Croce S, et al
    Adult Granulosa Cell Tumour With Heterologous Adipocytic Differentiation: Report of a Unique Case.
    Int J Gynecol Pathol. 2023;42:508-513.
    PubMed     Abstract available
    
    
    July 2023
47. CHUI MH, Grisham RN
    Somatic BAP1 Loss in Ovarian Serous Borderline Tumor and Recurrent Low-grade Serous Carcinoma From a Germline BAP1 Mutation Carrier.
    Int J Gynecol Pathol. 2023;42:432-433.
    PubMed    
    
    
    
48. TALHOUK A, Jamieson A, Crosbie EJ, Taylor A, et al
    Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing Protocol.
    Int J Gynecol Pathol. 2023;42:353-363.
    PubMed     Abstract available
    
    
    
49. BRAUN A, Reddy S, Cheng L, Gattuso P, et al
    Clinicopathologic Review of Metastatic Breast Cancer to the Gynecologic Tract.
    Int J Gynecol Pathol. 2023;42:414-420.
    PubMed     Abstract available
    
    
    
50. HALL KC, Post MD, Alldredge J, Aisner DL, et al
    Molecular Evidence for Epithelial Origin of Mixed Ovarian Epithelial-Germ Cell Neoplasms: Report of 2 Cases and Review of Literature.
    Int J Gynecol Pathol. 2023;42:403-413.
    PubMed     Abstract available
    
    
    
51. KOSTELECKY N, Ozhegov E, Cao D, Krigman H, et al
    Metastatic Cholangiocarcinoma to the Uterus Morphologically Imitating Primary Intestinal-type Endometrioid Adenocarcinoma.
    Int J Gynecol Pathol. 2023;42:398-402.
    PubMed     Abstract available
    
    
    
52. LAU JCC, McCluggage WG, Yuen LYP, Shing MMK, et al
    DICER1 -Altered Extraovarian Moderately Differentiated Sertoli-Leydig Cell Tumor: Report of a Rare Case.
    Int J Gynecol Pathol. 2023;42:421-425.
    PubMed     Abstract available
    
    
    
53. SUN Y, Liu-Jarin X, Hamele-Bena D, Murty VV, et al
    Ovarian Malignant Mixed Germ Cell Tumor With Prominent Embryoid Bodies (Polyembryoma Background): A Case Report and Literature Review.
    Int J Gynecol Pathol. 2023;42:426-431.
    PubMed     Abstract available
    
    
    May 2023
54. STRICKLAND AL, Maniar KP, Tanner E, Shanes E, et al
    Borderline With Bad Behavior: An Unusual Low-grade Serous Carcinoma With Dedifferentiation From a Serous Borderline Tumor.
    Int J Gynecol Pathol. 2023;42:241-246.
    PubMed     Abstract available
    
    
    
55. YOSHIDA H, Uno M, Ogimoto K, Kobayashi-Kato M, et al
    Endometrioid Endometrial Carcinoma With NKX3.1 Expression in a Transgender Man: A Case Report.
    Int J Gynecol Pathol. 2023;42:308-314.
    PubMed     Abstract available
    
    
    
56. OMO-OGBOI AC, Deavers MT, Schmeler KM, Tandon N, et al
    Collision Tumor of the Ovary Involving Sertoli-Leydig Cell Tumor and High-Grade Serous Carcinoma-Report of the First Case.
    Int J Gynecol Pathol. 2023;42:254-258.
    PubMed     Abstract available
    
    
    
57. MENDOZA R, Kertowidjojo E
    CTNNB1 -mutated High-grade Endometrioid Carcinoma With Extensive Squamous and Shadow Cell Differentiation Can Mimic Pilomatrix Carcinoma.
    Int J Gynecol Pathol. 2023;42:325-326.
    PubMed    
    
    
    
58. HALLING GC, Udager AM, Skala SL
    Endometrial, Ovarian, and Peritoneal Involvement by Endometrioid Carcinoma, Yolk Sac Tumor, and Endometriosis: Molecular Evidence for a Shared Precursor.
    Int J Gynecol Pathol. 2023;42:247-253.
    PubMed     Abstract available
    
    
    March 2023
59. DEVINS KM, Zukerberg L, Watkins JC, Hung YP, et al
    BAP1 and Claudin-4, But Not MTAP, Reliably Distinguish Borderline and Low-grade Serous Ovarian Tumors From Peritoneal Mesothelioma.
    Int J Gynecol Pathol. 2023;42:159-166.
    PubMed     Abstract available
    
    
    
60. MCHENRY A, Buza N
    Anastomosing Hemangioma of the Ovary With Leydig Cell Hyperplasia: A Clinicopathologic Study of 12 Cases.
    Int J Gynecol Pathol. 2023;42:167-175.
    PubMed     Abstract available
    
    
    
61. NILFOROUSHAN N, Liu L, Finkelman BS, Andersen J, et al
    Ovarian Combined Serous Borderline Tumor/Low-grade Serous Carcinoma and Mesonephric-like Lesion: Report of 2 Cases With New Observations.
    Int J Gynecol Pathol. 2023;42:182-191.
    PubMed     Abstract available
    
    
    
62. DUNDAR B, Alrwashdeh A, Dahmoush L
    Tumor to Tumor Metastasis: A Case Report of Metastatic Angiosarcoma to an Ovarian Brenner Tumor and Review of the Literature.
    Int J Gynecol Pathol. 2023;42:176-181.
    PubMed     Abstract available
    
    
    
63. BANET N, Masnick M, Quddus MR
    Evaluation of Saccharomyces cerevisiae -like 1 (SEC14L1) in Gynecologic Malignancies Shows Overexpression in Endometrial Serous Carcinoma.
    Int J Gynecol Pathol. 2023;42:136-142.
    PubMed     Abstract available
    
    
    January 2023
64. COPPOCK JD, Gradecki SE, Mills AM
    PRAME Expression in Endometrioid and Serous Endometrial Carcinoma: A Potential Immunotherapeutic Target and Possible Diagnostic Pitfall.
    Int J Gynecol Pathol. 2023;42:35-42.
    PubMed     Abstract available
    
    
    
65. KOUCHI Y, Komatsu S, Harada S, Shinomiya Y, et al
    Ovarian Malignant Mixed Germ Cell Tumor Composed Mainly of a Polyembryoma Pattern With Vasculogenic Mesenchymal Tumor Components.
    Int J Gynecol Pathol. 2023;42:78-82.
    PubMed     Abstract available
    
    
    
66. ALBRIGHT BB, Wignall E, Bentley RC, Havrilesky LJ, et al
    BAP1 Tumor Predisposition Syndrome Presenting as a Recurrent Ovarian Sex Cord-Stromal Tumor.
    Int J Gynecol Pathol. 2023;42:83-88.
    PubMed     Abstract available
    
    
    
67. TALIA KL, McCluggage WG
    Microscopic Sertoliform Sex Cord Proliferations: A Rare Incidental Finding Associated With Endometriosis and Ovarian Epithelial Neoplasia.
    Int J Gynecol Pathol. 2023;42:70-77.
    PubMed     Abstract available
    
    
    
68. HAAG JG, Wolsky RJ, Moroney MR, Sheren J, et al
    Clinicopathologic Evaluation of CTNNB1 Mutations in High-Intermediate Risk Endometrial Endometrioid Carcinoma.
    Int J Gynecol Pathol. 2023;42:43-53.
    PubMed     Abstract available
    
    
    
69. CHANG CS, Carney ME, Killeen JL
    Two Cases of Mesonephric-like Carcinoma Arising From Endometriosis: Case Report and Review of the Literature.
    Int J Gynecol Pathol. 2023;42:101-107.
    PubMed     Abstract available
    
    
    
70. ARCIUOLO D, Travaglino A, Santoro A, Roberti P, et al
    Pilomatrix-like High-grade Endometrioid Carcinoma is a Morphologically and Immunophenotypically Distinct Entity and May Show Mismatch Repair Deficiency.
    Int J Gynecol Pathol. 2023;42:68-69.
    PubMed    
    
    
    
71. GREGORY-DAVIS KJ, Walker A, Colello LS, McKinnon W, et al
    Serous Tubal Intraepithelial Carcinoma in a Risk-reducing Salpingo-oophorectomy Specimen From a RAD51D Mutation Carrier: A Case Report.
    Int J Gynecol Pathol. 2023;42:89-92.
    PubMed     Abstract available
    
    
    
72. MCMULLEN-TABRY ER, Sciallis AP, Udager AM, Skala SL, et al
    Unusual Ovarian Tumors With Endometrioid Proliferations Co-Expressing Estrogen Receptor and CDX-2 Arising in Cystadenofibromatous Background: Report of 3 Cases.
    Int J Gynecol Pathol. 2023;42:93-100.
    PubMed     Abstract available
    
    
    
73. SHARMA AE, Moran A, Somasegar S, Steinhardt G, et al
    Clinicopathologic Evaluation and Molecular Profiling of Recurrent Stage IA Endometrial Endometrioid Carcinoma: A Case-control Study.
    Int J Gynecol Pathol. 2023;42:26-34.
    PubMed     Abstract available
    
    
    
74. YIN X, Wang M, He H, Ru G, et al
    Uterine Tumor Resembling Ovarian Sex Cord Tumor With Aggressive Histologic Features Harboring a GREB1-NCOA2 Fusion: Case Report With a Brief Review.
    Int J Gynecol Pathol. 2023;42:54-62.
    PubMed     Abstract available
    
    
    November 2022
75. GILL SJ, Pirzada A, Power P, Neveu J, et al
    A Constellation of Rare Gynecological Malignancies and Familial Adenomatous Polyposis Gastrointestinal Adenocarcinoma: A Case Report.
    Int J Gynecol Pathol. 2022;41:622-627.
    PubMed     Abstract available
    
    
    
76. ARCIUOLO D, Travaglino A, Santoro A, Pedone Anchora L, et al
    Postchemotherapy Endometrioid to Gastrointestinal Histotype Shift in Recurrent Endometrial Carcinoma.
    Int J Gynecol Pathol. 2022;41:583-587.
    PubMed     Abstract available
    
    
    
77. SAUER MA, Coy S, Quade BJ, Nucci MR, et al
    Well-developed Cerebellum in an Ovarian Mature Teratoma From a Pregnant Female.
    Int J Gynecol Pathol. 2022;41:615-621.
    PubMed     Abstract available
    
    
    
78. DEVEREAUX KA, Steiner DF, Ho C, Gomez AJ, et al
    A Multiplex SNaPshot Assay is a Rapid and Cost-Effective Method for Detecting POLE Exonuclease Domain Mutations in Endometrial Carcinoma.
    Int J Gynecol Pathol. 2022;41:541-551.
    PubMed     Abstract available
    
    
    
79. DAHOUD W, Handler J, Parimi V, Meyer CF, et al
    Adult Granulosa Cell Tumor With Sarcomatous Transformation: A Case Study With Emphasis on Molecular Alterations.
    Int J Gynecol Pathol. 2022;41:600-607.
    PubMed     Abstract available
    
    
    July 2022
80. AKBARZADEH-JAHROMI M, Aslani FS, Raeisi H, Momtahan M, et al
    Comparison of Frozen and Permanent Section Diagnosis in Ovarian Neoplasms: Analysis of Factors Affecting Accuracy.
    Int J Gynecol Pathol. 2022;41:327-336.
    PubMed     Abstract available
    
    
    
81. SHETTY D, Bhalekar S, Rao S, Mukharji S, et al
    Cystic Ovarian Mucinous Carcinoma With Carcinosarcomatous Mural Nodules: An Uncommon Entity.
    Int J Gynecol Pathol. 2022;41:343-348.
    PubMed     Abstract available
    
    
    
82. MCCLUGGAGE WG, Fu L, Mohler K, de Kock L, et al
    An Unusual Enteric Yolk Sac Tumor: First Report of an Ovarian Germ Cell Tumor Associated With a Germline Pathogenic Variant in DICER1.
    Int J Gynecol Pathol. 2022;41:349-355.
    PubMed     Abstract available
    
    
    
83. MATSON DR, Accola MA, Henderson L, Shao X, et al
    A "Null" Pattern of p16 Immunostaining in Endometrial Serous Carcinoma: An Under-recognized and Important Aberrant Staining Pattern.
    Int J Gynecol Pathol. 2022;41:378-388.
    PubMed     Abstract available
    
    
    
84. LU B, Shi H, Shao Y, Xu J, et al
    Ovarian Metastasis by Gastric-type Endocervical Adenocarcinoma: A Clinicopathologic Description of 12 Cases.
    Int J Gynecol Pathol. 2022;41:356-365.
    PubMed     Abstract available
    
    
    
85. GUIDO LP, Camacho F, Freire R, Pinto A, et al
    Unusual Variants of Teratoma Involving the Gynecologic Tract.
    Int J Gynecol Pathol. 2022;41:320-326.
    PubMed     Abstract available
    
    
    
86. PARRA-HERRAN C
    Endometrioid Tubal Intraepithelial Neoplasia and Bilateral Ovarian Microcystic Stromal Tumors Harboring APC Mutations: Report of a Case.
    Int J Gynecol Pathol. 2022;41:337-342.
    PubMed     Abstract available
    
    
    May 2022
87. MATRAI CE, Ohara K, Eng KW, Glynn SM, et al
    Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence.
    Int J Gynecol Pathol. 2022;41:207-219.
    PubMed     Abstract available
    
    
    
88. PETERS EEM, Leon-Castillo A, Hogdall E, Boennelycke M, et al
    Substantial Lymphovascular Space Invasion Is an Adverse Prognostic Factor in High-Risk Endometrial Cancer.
    Int J Gynecol Pathol. 2022;41:227-234.
    PubMed     Abstract available
    
    
    
89. MCMULLEN ER, Huang T, Skala SL
    Large Ovarian Follicle Cyst: Benign Mimic of Cystic Adult Granulosa Cell Tumor.
    Int J Gynecol Pathol. 2022;41:289-291.
    PubMed     Abstract available
    
    
    
90. MCGINN B, Lemaire AS, McCluggage WG
    Ovarian Low-grade Basaloid Carcinoma Arising in Brenner Tumor: A New Variant of Malignant Brenner Tumor.
    Int J Gynecol Pathol. 2022;41:276-284.
    PubMed     Abstract available
    
    
    March 2022
91. GANESAN R, Gilks CB, Soslow RA, McCluggage WG, et al
    Survey on Reporting of Endometrial Biopsies From Women on Progestogen Therapy for Endometrial Atypical Hyperplasia/Endometrioid Carcinoma.
    Int J Gynecol Pathol. 2022;41:142-150.
    PubMed     Abstract available
    
    
    
92. WEISMAN P, Park KJ, Xu J
    FIGO Grade 3 Endometrioid Adenocarcinomas With Diffusely Aberrant beta-Catenin Expression: An Aggressive Subset Resembling Cutaneous Pilomatrix Carcinomas.
    Int J Gynecol Pathol. 2022;41:126-131.
    PubMed     Abstract available
    
    
    
93. RAJENDRAN S, McCluggage WG
    WT1 Positive Ovarian Endometrioid Tumors: Observations From Consult Cases and Strategies for Distinguishing From Serous Neoplasms.
    Int J Gynecol Pathol. 2022;41:191-202.
    PubMed     Abstract available
    
    
    
94. CAGAANAN A, Stelter B, Vu N, Rhode EN, et al
    HER2 Expression in Endometrial Cancers Diagnosed as Clear Cell Carcinoma.
    Int J Gynecol Pathol. 2022;41:132-141.
    PubMed     Abstract available
    
    
    
95. RAJENDRAN S, Boyd C, Shah R, Stewart CJR, et al
    Bronchus-like Structures in Ovarian Teratomas: Report of a Series of a Previously Unreported Phenomenon With Potential For Misdiagnosis.
    Int J Gynecol Pathol. 2022;41:180-185.
    PubMed     Abstract available
    
    
    
96. WIEDEMEYER K, Wang L, Kang EY, Liu S, et al
    Prognostic and Theranostic Biomarkers in Ovarian Clear Cell Carcinoma.
    Int J Gynecol Pathol. 2022;41:168-179.
    PubMed     Abstract available
    
    
    January 2022
97. VROOBEL KM, McCluggage WG
    Ovarian Clear Cell Tumors Associated With Seromucinous Borderline Tumor: A Case Series.
    Int J Gynecol Pathol. 2022;41:76-81.
    PubMed     Abstract available
    
    
    
98. SHAH VI, Morgan SE, Kobel M, Lee CH, et al
    Dedifferentiation in Breast Metastasis of Endometrial Carcinoma: A Diagnostic Dilemma.
    Int J Gynecol Pathol. 2022;41:35-39.
    PubMed     Abstract available
    
    
    
99. WANG L, Piskorz A, Bosse T, Jimenez-Linan M, et al
    Immunohistochemistry and Next-generation Sequencing Are Complementary Tests in Identifying PTEN Abnormality in Endometrial Carcinoma Biopsies.
    Int J Gynecol Pathol. 2022;41:12-19.
    PubMed     Abstract available
    
    
    
100. WATKINS JC, Young RH
     Mullerian Mucinous Cystadenomas of the Ovary: A Report of 25 Cases of an Unheralded Benign Ovarian Neoplasm Often Associated With Endometriosis and a Brief Consideration of Neoplasms Arising From the Latter.
     Int J Gynecol Pathol. 2022;41:68-75.
     PubMed     Abstract available
     
     
     
101. CAO J, Hacking S, Chavarria-Bernal HD, Bhuiya TA, et al
     Androgen Receptor Immunohistochemical Expression in Undifferentiated/Dedifferentiated Endometrial Carcinoma.
     Int J Gynecol Pathol. 2022;41:28-34.
     PubMed     Abstract available
     
     
     November 2021
102. KWON DH, Malpica A, Zaleski M, Euscher ED, et al
     Immunohistochemical Loss of DPC4 in Tumors With Mucinous Differentiation Arising in or Involving the Gynecologic Tract.
     Int J Gynecol Pathol. 2021;40:523-532.
     PubMed     Abstract available
     
     
     
103. ABU-SINN D, Jamison J, Evans M, McCluggage WG, et al
     Pelvic and Ovarian Recurrence of Small HPV-associated Cervical Adenocarcinoma With Transformation to Neuroendocrine Carcinoma.
     Int J Gynecol Pathol. 2021;40:541-548.
     PubMed     Abstract available
     
     
     
104. JHA S, Mitra S, Patra S, Sethi P, et al
     Krukenberg Tumor of Ovary During Pregnancy: Learning From A Mistake.
     Int J Gynecol Pathol. 2021;40:617-620.
     PubMed     Abstract available
     
     
     
105. KARPATHIOU G, Chauleur C, Dal Col P, Peoc'h M, et al
     FOXA1 Expression by Immunohistochemistry in Carcinosarcomas of the Endometrium and Ovary/Fallopian Tube.
     Int J Gynecol Pathol. 2021;40:611-616.
     PubMed     Abstract available
     
     
     September 2021
106. OLIVADESE R, Ramponi A, Boldorini R, Dalla Dea G, et al
     Mitotically Active Cellular Fibroma of the Ovary Recurring After the Longest Interval of Time (16 yr): A Challenging Case With Systematic Literature Review.
     Int J Gynecol Pathol. 2021;40:441-447.
     PubMed     Abstract available
     
     
     
107. CATTEAU X, Preat F, D'haene N, Noel JC, et al
     Osseous Metaplasia in Low-grade Ovarian Serous Carcinoma With a BRAF Mutation: A Case Report.
     Int J Gynecol Pathol. 2021;40:448-451.
     PubMed     Abstract available
     
     
     
108. NAGAR R, Peters T, Nagar H, McCluggage WG, et al
     Diagnostic Accuracy in Assessment of Depth of Myometrial Invasion in Low-grade Endometrioid Carcinoma: A 2 Center Comparative Study by MRI and Intraoperative Assessment.
     Int J Gynecol Pathol. 2021;40:495-500.
     PubMed     Abstract available
     
     
     July 2021
109. LAI J, Garvey KY, Li P, Azevedo RA, et al
     Primary Ovarian Melanoma Arising From a Mature Teratoma With Melanoma In Situ Present in the Ciliated Columnar and Squamous Epithelium in a Patient With Synchronous Skin Basal Cell Carcinoma.
     Int J Gynecol Pathol. 2021;40:383-390.
     PubMed     Abstract available
     
     
     
110. D'ANTONIO A, Caleo A, Addesso M, Caputo A, et al
     A Rare Case of Castleman Disease Presenting as an Ovarian Tumor.
     Int J Gynecol Pathol. 2021;40:379-382.
     PubMed     Abstract available
     
     
     
111. SALISBURY T, Gilks CB
     Immunoreactive Acellular Keratin in Sentinel Lymph Nodes From a Patient With Endometrioid Carcinoma of the Endometrium With Squamous Differentiation: A Case Report of a Potential Diagnostic Pitfall.
     Int J Gynecol Pathol. 2021;40:355-358.
     PubMed     Abstract available
     
     
     
112. WATKINS JC, Young RH
     Follicle Cysts of the Ovary: A Report of 30 Cases of a Common Benign Lesion Emphasizing its Unusual Clinical and Pathologic Aspects.
     Int J Gynecol Pathol. 2021;40:359-368.
     PubMed     Abstract available
     
     
     
113. HEIMBIGNER AM, Davaro EP, Schwetye K
     Benign Brenner Tumor in an Ectopic Ovary: A Case Report and Review of Literature.
     Int J Gynecol Pathol. 2021;40:376-378.
     PubMed     Abstract available
     
     
     May 2021
114. ZHANG L, Velazquez M, Wang X, Masand R, et al
     Ovarian Mixed Epithelial Carcinoma With Extensive Bilateral Fallopian Tubes Metastases by the Low-grade Serous Carcinoma Component Mimicking Serous Tubal Intraepithelial Carcinoma: Case Presentation and Literature Review.
     Int J Gynecol Pathol. 2021;40:305-309.
     PubMed     Abstract available
     
     
     
115. WRIGHT MF, Fitzlaff S, Wyeth A, Zaragoza-Watkins M, et al
     Nuclear Beta-Catenin Expression in Endometrioid Intraepithelial Neoplasia (Atypical Hyperplasia) Does Not Predict Carcinoma on Subsequent Hysterectomy.
     Int J Gynecol Pathol. 2021;40:240-247.
     PubMed     Abstract available
     
     
     
116. HODGSON A, Ghorab Z, Parra-Herran C
     Somatically Derived Yolk Sac Tumor of the Ovary in a Young Woman.
     Int J Gynecol Pathol. 2021;40:296-300.
     PubMed     Abstract available
     
     
     
117. HALVORSON TS, Robinson RA, Samuelson MI
     Pure Primary Ovarian Carcinoid Tumor.
     Int J Gynecol Pathol. 2021;40:301-304.
     PubMed     Abstract available
     
     
     
118. SHARMA AE, Hamedani FS, Barroeta JE, Pytel P, et al
     Clear Cell Papillary Cystadenoma of the Ovary Masquerading as Metastatic Clear Cell Renal Cell Carcinoma: A Case Report and Review of the Literature.
     Int J Gynecol Pathol. 2021;40:290-295.
     PubMed     Abstract available
     
     
     March 2021
119. LADWIG NR, Umetsu SE, Zaloudek C, Rabban J, et al
     Corded and Hyalinized Endometrioid Adenocarcinoma (CHEC) of the Uterine Corpus are Characterized by CTNNB1 Mutations and Can Show Adverse Clinical Outcomes.
     Int J Gynecol Pathol. 2021;40:103-115.
     PubMed     Abstract available
     
     
     
120. BENNETT JA, Safdar N, Segal JP, Lastra RR, et al
     Evaluation of SWI/SNF Protein Expression by Immunohistochemistry in Ovarian Clear Cell Carcinoma.
     Int J Gynecol Pathol. 2021;40:156-164.
     PubMed     Abstract available
     
     
     
121. GUERRIERI C, Anderson P, Hudacko R
     Ciliated Carcinoma of the Endometrium.
     Int J Gynecol Pathol. 2021;40:141-147.
     PubMed     Abstract available
     
     
     
122. LIN SY, Hang JF, Lin YY, Lai CR, et al
     Diffuse Intratumoral Stromal Inflammation in Ovarian Clear Cell Carcinoma is Associated With Loss of Mismatch Repair Protein and High PD-L1 Expression.
     Int J Gynecol Pathol. 2021;40:148-155.
     PubMed     Abstract available
     
     
     
123. BRETT MA, Atenafu EG, Singh N, Ghatage P, et al
     Equivalent Survival of p53 Mutated Endometrial Endometrioid Carcinoma Grade 3 and Endometrial Serous Carcinoma.
     Int J Gynecol Pathol. 2021;40:116-123.
     PubMed     Abstract available
     
     
     
124. KATSAKHYAN L, Baraban EG, Dumoff KL, Burger RA, et al
     The "Far Left" of the Morphologic Spectrum of Ovarian High-grade Serous Carcinoma: Case Report of a Purely Noninvasive High-grade Serous Carcinoma Mimicking an Ovarian Serous Borderline Tumor.
     Int J Gynecol Pathol. 2021;40:175-179.
     PubMed     Abstract available
     
     
     January 2021
125. KOBEL M, Kang EY
     The Many Uses of p53 Immunohistochemistry in Gynecological Pathology: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual9 Meeting.
     Int J Gynecol Pathol. 2021;40:32-40.
     PubMed     Abstract available
     
     
     
126. TAYLOR J, Shah R, McElvanna K, Kelly PJ, et al
     Late Development of Metastatic Ovarian Mucinous Adenocarcinoma From Primary Gallblader Adenocarcinoma and High-grade Dysplasia.
     Int J Gynecol Pathol. 2021;40:41-48.
     PubMed     Abstract available
     
     
     
127. CRASTA J, Ravikumar G, Rajarajan S, Gali S, et al
     Expression of HER2 and EGFR Proteins in Advanced Stage High-grade Serous Ovarian Tumors Show Mutual Exclusivity.
     Int J Gynecol Pathol. 2021;40:49-55.
     PubMed     Abstract available
     
     
     
128. STEWART CJR, Harding S
     Stromal Endocrine Cell Micronests Associated With an Ovarian Mucinous Cystadenoma: Endocrine Cell Preservation (Pseudohyperplasia) Potentially Mimicking Stromal Sex Cord Proliferation or Tumor Microinvasion.
     Int J Gynecol Pathol. 2021;40:56-59.
     PubMed     Abstract available
     
     
     July 2020
129. FEDDA FA, Euscher ED, Ramalingam P, Malpica A, et al
     Prophylactic Risk-reducing Hysterectomies and Bilateral Salpingo-oophorectomies in Patients With Lynch Syndrome: A Clinicopathologic Study of 29 Cases and Review of the Literature.
     Int J Gynecol Pathol. 2020;39:313-320.
     PubMed     Abstract available
     
     
     
130. TRENTO M, Munari G, Carraro V, Lanza C, et al
     Mutational and Immunophenotypic Profiling of a Series of 8 Tubo-ovarian Carcinosarcomas Revealed a Monoclonal Origin of the Disease.
     Int J Gynecol Pathol. 2020;39:305-312.
     PubMed     Abstract available
     
     
     
131. LENGYEL K, Young F, Kucukmetin A, Cresti N, et al
     BRAF Wild-type, PTEN Mutant Malignant Uveal Melanoma Arising Within a Mature Ovarian Teratoma: A Case Report and Review of the Literature.
     Int J Gynecol Pathol. 2020;39:321-326.
     PubMed     Abstract available
     
     
     
132. ABBAS A, Ud Din N, Kayani N
     Synchronous Well-differentiated Endometrioid Adenocarcinoma and Leiomyosarcoma of the Uterus With Pulmonary Metastasis in a 50-Yr-Old Woman: A Case Report and Review of Literature.
     Int J Gynecol Pathol. 2020;39:373-378.
     PubMed     Abstract available
     
     
     May 2020
133. ABOZINA A, Singh N, Blake C
     Transtubal Spread of a Superficially Invasive Cervical Adenocarcinoma to the Ovaries After 11 Years.
     Int J Gynecol Pathol. 2020;39:296-300.
     PubMed     Abstract available
     
     
     
134. MEYDANLI MM, Aslan K, Oz M, Muftuoglu KH, et al
     Is It Possible to Develop a Prediction Model for Lymphovascular Space Invasion in Endometrioid Endometrial Cancer?
     Int J Gynecol Pathol. 2020;39:213-220.
     PubMed     Abstract available
     
     
     
135. FAHOUM I, Brazowski E, Hershkovitz D, Aizic A, et al
     Tumor-to-Tumor Metastasis of Colorectal Adenocarcinoma to Ovarian Cystadenofibroma: A Case Report and Review of the Literature.
     Int J Gynecol Pathol. 2020;39:270-272.
     PubMed     Abstract available
     
     
     
136. CHAPEL DB, Lengyel E, Ritterhouse LL, Lastra RR, et al
     Interpretation of Mismatch Repair Protein Immunohistochemistry in Endometrial Carcinoma Should Consider Both Lynch Syndrome Screening and Immunotherapy Susceptibility: An Illustrative Case Report.
     Int J Gynecol Pathol. 2020;39:233-237.
     PubMed     Abstract available
     
     
     March 2020
137. BROUWER J, Strickland KC, Ning G, Schmelkin CB, et al
     Evidence for a Novel Endometrioid Carcinogenic Sequence in the Fallopian Tube With Unique Beta-Catenin Expression.
     Int J Gynecol Pathol. 2020;39:163-169.
     PubMed     Abstract available
     
     
     
138. ZHANG X, Guo J, Yang L, Zhao Y, et al
     Ovarian Sclerosing Stromal Tumor and Mullerian Cyst in an 11-yr-old Girl: A Case Report and Review of the Literature.
     Int J Gynecol Pathol. 2020;39:e5-e10.
     PubMed     Abstract available
     
     
     
139. BAI S, Hutchinson LM, Meng X, Bai H, et al
     Dedifferentiated Carcinoma of the Endometrium Associated With Low-grade Mullerian Adenosarcoma: A Clinicopathologic Case Report Including the Immunohistochemical and Molecular Profile.
     Int J Gynecol Pathol. 2020;39:141-145.
     PubMed     Abstract available
     
     
     
140. VOS MC, Hollemans E, van der Steen SCHA, van Kuppevelt TH, et al
     Primary Ovarian Tumors With Lymphogenic and Hematogenic Metastasis Express High MMP-14, Which Colocalizes With Highly Sulfated Chondroitin Sulfate in the Stroma.
     Int J Gynecol Pathol. 2020;39:184-192.
     PubMed     Abstract available
     
     
     
141. COSTIGAN DC, Dong F, Nucci MR, Howitt BE, et al
     Clinicopathologic and Immunohistochemical Correlates of CTNNB1 Mutated Endometrial Endometrioid Carcinoma.
     Int J Gynecol Pathol. 2020;39:119-127.
     PubMed     Abstract available
     
     
     
142. CHEN PH, Hui P, Buza N
     Bilateral Signet-ring Stromal Tumor of the Ovary: A Case Report With Next-generation Sequencing Analysis and FOXL2 Mutation Testing.
     Int J Gynecol Pathol. 2020;39:193-198.
     PubMed     Abstract available
     
     
     
143. CHIESA-VOTTERO A
     CDX2, SATB2, GATA3, TTF1, and PAX8 Immunohistochemistry in Krukenberg Tumors.
     Int J Gynecol Pathol. 2020;39:170-177.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.